ReviewAnnals of medicine and surgery (2012)2025
Diagnostic advancements in early detection of diabetic neuropathy: comparative analysis of medial and lateral plantar nerve degeneration.
Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic neuropathy (DN) is a widespread complication of diabetes, affecting nearly 50% of individuals with the condition. It commonly begins with the gradual loss of sensation in the lower extremities, particularly in the feet. If left undetected and untreated, this loss of sensation can lead to serious consequences, such as foot ulcers and eventual amputations. Early detection is critical to preventing irreversible nerve damage and minimizing the risk of such severe outcomes. However, current diagnostic methods often fail to identify neuropathy at an early stage, when intervention could still halt or reverse nerve degeneration. The medial and lateral plantar nerves, responsible for sensory innervation in the foot, are among the first to show signs of damage in DN. Monitoring these nerves offers a potential avenue for early diagnosis. Techniques such as nerve conduction studies (NCS) and quantitative sensory testing (QST) allow for the assessment of nerve function in the distal extremities, where neuropathy typically begins. Early identification of nerve dysfunction through these methods can lead to timely intervention, significantly improving patient outcomes and reducing the risk of severe complications. Addressing the early signs of neuropathy is essential in managing the growing prevalence of diabetes-related complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.